Retroperitoneal Lymph Node Dissection (RPLND) as an alternative treatment strategy for low-volume, clinical stage II testicular seminoma: a survey of patients and providers
ConclusionsOur surveys found that the majority of patients and providers would be willing to participate in a trial of RPLND as an alternative treatment strategy for low-volume, CSII testicular seminoma.
Source: Urology Practice - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Radiation Therapy | Seminoma | Study | Testicular Cancer | Urology & Nephrology